DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
PIM-35 is an investigational drug.
There have been 9 clinical trials for PIM-35. The most recent clinical trial was a Phase 2 trial, which was initiated on May 4th 2015.
The most common disease conditions in clinical trials are Neoplasms, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Astex Pharmaceuticals, Inc., Astex Pharmaceuticals, and Incyte Corporation.
There is one US patent protecting this investigational drug and eighteen international patents.
Recent Clinical Trials for PIM-35
|Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)||Astex Pharmaceuticals||Phase 1/Phase 2|
|Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)||Astex Pharmaceuticals, Inc.||Phase 1/Phase 2|
|Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)||Incyte Corporation||Phase 1/Phase 2|
Top disease conditions for PIM-35
Top clinical trial sponsors for PIM-35
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|PIM-35||⤷ Try it Free||Indole derivatives||Consejo Superior de Investigaciones Cientificas (Madrid, ES)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|PIM-35||Austria||AT85047||2009-02-08||⤷ Try it Free|
|PIM-35||Australia||AU5029990||2009-02-08||⤷ Try it Free|
|PIM-35||Australia||AU626640||2009-02-08||⤷ Try it Free|
|PIM-35||Canada||CA2025663||2009-02-08||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|